Resapp Health Ltd
ASX:RAP
Resapp Health Ltd
ASX:RAP
Price:
0.205 AUD
Market Closed
Updated:
Apr 27, 2024
P/E
Price to Earnings
Price to Earnings
-24.8
Current
-24.8
Median
23.2
Industry
Higher
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=-24.8
Market Cap
/
176.2m
Net Income
-7.1m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| AU |
|
Resapp Health Ltd
ASX:RAP
|
176.2m AUD | -24.8 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.4B USD | 61.6 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 47.3 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | -116.8 | |
| JP |
|
M3 Inc
TSE:2413
|
1.3T JPY | 27.5 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
11.4B AUD | 163.9 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
7B USD | -331.8 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.4B USD | 32.2 | |
| SE |
|
Sectra AB
STO:SECT B
|
42.7B SEK | 100.6 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.1B USD | -22.1 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | -319.5 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
N/A
2-Years Forward
P/E
N/A
3-Years Forward
P/E
N/A
You don't have any saved screeners yet
